Glycated Serum Protein

1. What Is Glycated Serum Protein?

Glycated Serum Protein (GSP) refers to serum proteins—mainly albumin—that have undergone non-enzymatic glycation by glucose. This process forms early glycation products (such as fructosamine) and, over time, can lead to advanced glycation end products (AGEs).

Because serum proteins have a shorter lifespan (about 14–21 days) than red blood cells, GSP reflects average blood glucose levels over the previous 2–3 weeks.

2. Clinical Importance

A. Short-Term Glycemic Monitoring

• Provides an assessment of recent glycemic control (2–3 weeks).

• Useful when rapid changes in therapy occur (e.g., insulin adjustments).

• More responsive to recent glucose fluctuations than HbA1c.

B. Alternative to HbA1c

GSP is particularly helpful when HbA1c measurements may be unreliable, such as in:

• Hemolytic anemia

• Recent blood transfusion

• Pregnancy

• Chronic kidney disease

• Hemoglobinopathies

In these cases, HbA1c may not accurately reflect glycemic status due to altered red blood cell lifespan.

3. Relationship with Diabetes Mellitus

In patients with:

• Type 1 Diabetes Mellitus

• Type 2 Diabetes Mellitus

• Gestational diabetes

Elevated GSP levels indicate:

• Poor short-term glycemic control

• Increased risk of early diabetic complications

Persistent protein glycation contributes to:

• Microvascular damage (retinopathy, nephropathy, neuropathy)

• Endothelial dysfunction

• Oxidative stress

4. Clinical Applications

• Monitoring diabetes when HbA1c is unreliable

• Assessing short-term glycemic trends

• Evaluating compliance with treatment

• Monitoring gestational diabetes

• Research on glycation and diabetic complications

5. Limitations

• Affected by serum protein levels (e.g., hypoalbuminemia)

• Altered in liver disease

• May be influenced by thyroid disorders

• Less standardized than HbA1c